Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
49 hedge funds and large institutions have $8.12M invested in Genesis Healthcare, Inc. in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 13 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
11% less funds holding
Funds holding: 55 → 49 (-6)
34% less capital invested
Capital invested by funds: $12.3M → $8.12M (-$4.23M)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
50% less call options, than puts
Call options by funds: $6K | Put options by funds: $12K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$283K |
| 2 |
Squarepoint
New York
|
+$99.7K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$43.1K |
| 4 |
VF
Virtu Financial
New York
|
+$24.3K |
| 5 |
Two Sigma Advisers
New York
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
V3 Capital Management
Dallas,
Texas
|
-$1.63M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.52M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
-$313K |
| 4 |
Jane Street
New York
|
-$72K |
| 5 |
Renaissance Technologies
New York
|
-$62.6K |
GEN Hedge Fund Activity: Q4 2020 in Review
49 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2020, worth a combined $8.12M — down 34% from $12.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of GEN and 7 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 12 added.
The largest buyer was Acadian Asset Management, adding an estimated $283K. The largest seller was V3 Capital Management, exiting entirely with an estimated $1.63M sold.
- 49 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2020, down from 55 in Q3 2020.
- Funds reported $8.12M of Genesis Healthcare, Inc. stock for Q4 2020, down 34% quarter-over-quarter.
- 7 funds opened new Genesis Healthcare, Inc. positions in Q4 2020 and 13 closed out, a net change of -6 holders.
- The largest Genesis Healthcare, Inc. buyer in Q4 2020 was Acadian Asset Management, an estimated $283K added.
- The largest Genesis Healthcare, Inc. seller in Q4 2020 was V3 Capital Management, an estimated $1.63M sold.
Based on aggregated 13F filings for Q4 2020.